VEGFA and peripheral arterial disease: In the treatment of critical limb ischemia (CLI), a severe form of peripheral artery disease characterized by reduced blood flow to the limbs, vascular endothelial growth factor (VEGF) serves as a powerful example of a growth factor that activates endogenous stem cells to achieve therapeutic effects.